Pillstats
Rx only · Tablet, Film Coated · Oral

Olmesartan Medoxomil And Hydrochlorothiazide

Hydrochlorothiazide + Olmesartan Medoxomil

10 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US32 NDCs
10 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers10 labelers
Packages77
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 31 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.062$0.124$0.186$0.248Dec 2025Apr 2026Jun 2026
$0.216
Latest avg · Jun 17, 2026
+8%
Since Dec 17, 2025
10
Active US suppliers
31%
Top-2 supplier share*

Who makes it10 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Macleods Pharmaceuticals Limitedunknown12SUPPLYING
Bryant Ranch Prepackrepackager12SUPPLYING
Aurobindo Pharma Limitedunknown10SUPPLYING
Camber Pharmaceuticals, Inc.unknown9SUPPLYING
ScieGen Pharmaceuticals, Inc.unknown9SUPPLYING
A-S Medication Solutionsunknown8SUPPLYING
NorthStar RxLLCunknown6SUPPLYING
Ascend Laboratories, LLCunknown6SUPPLYING
Accord Healthcare Inc.unknown3SUPPLYING
REMEDYREPACK INC.repackager2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.